Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / GENOMICS IMMUN
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
1,869,472
-
Shares change
-
+442,048
-
Total reported value, excl. options
-
$90,061,576
-
Value change
-
+$20,195,651
-
Number of buys
-
47
-
Number of sells
-
-16
-
Price
-
$45.71
Significant Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q1 2021
82 filings reported holding IDNA - ISHARES TR - GENOMICS IMMUN as of Q1 2021.
ISHARES TR - GENOMICS IMMUN (IDNA) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,869,472 shares
.
Largest 10 shareholders include UBS Group AG (235,787 shares), JANE STREET GROUP, LLC (216,041 shares), Thrivent Financial for Lutherans (188,957 shares), BANK OF AMERICA CORP /DE/ (134,184 shares), Wharton Business Group, LLC (118,735 shares), LPL Financial LLC (108,623 shares), ROYAL BANK OF CANADA (92,902 shares), Wealthcare Advisory Partners LLC (89,268 shares), RETIREMENT CAPITAL STRATEGIES (88,049 shares), and Sharkey, Howes & Javer (64,798 shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.